1. Home
  2. DVA vs WLK Comparison

DVA vs WLK Comparison

Compare DVA & WLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • WLK
  • Stock Information
  • Founded
  • DVA 1994
  • WLK 1986
  • Country
  • DVA United States
  • WLK United States
  • Employees
  • DVA N/A
  • WLK N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • WLK Major Chemicals
  • Sector
  • DVA Health Care
  • WLK Industrials
  • Exchange
  • DVA Nasdaq
  • WLK Nasdaq
  • Market Cap
  • DVA 10.5B
  • WLK 9.2B
  • IPO Year
  • DVA 1995
  • WLK 2004
  • Fundamental
  • Price
  • DVA $135.44
  • WLK $84.03
  • Analyst Decision
  • DVA Hold
  • WLK Buy
  • Analyst Count
  • DVA 2
  • WLK 15
  • Target Price
  • DVA $162.00
  • WLK $96.60
  • AVG Volume (30 Days)
  • DVA 925.7K
  • WLK 1.4M
  • Earning Date
  • DVA 08-05-2025
  • WLK 08-05-2025
  • Dividend Yield
  • DVA N/A
  • WLK 2.50%
  • EPS Growth
  • DVA 8.72
  • WLK N/A
  • EPS
  • DVA 10.20
  • WLK N/A
  • Revenue
  • DVA $13,161,328,000.00
  • WLK $11,759,000,000.00
  • Revenue This Year
  • DVA $6.51
  • WLK N/A
  • Revenue Next Year
  • DVA $3.41
  • WLK $6.43
  • P/E Ratio
  • DVA $13.28
  • WLK N/A
  • Revenue Growth
  • DVA 5.09
  • WLK N/A
  • 52 Week Low
  • DVA $126.07
  • WLK $68.55
  • 52 Week High
  • DVA $179.60
  • WLK $153.34
  • Technical
  • Relative Strength Index (RSI)
  • DVA 46.24
  • WLK 54.22
  • Support Level
  • DVA $128.28
  • WLK $76.21
  • Resistance Level
  • DVA $135.58
  • WLK $85.12
  • Average True Range (ATR)
  • DVA 3.76
  • WLK 3.40
  • MACD
  • DVA -0.39
  • WLK 0.31
  • Stochastic Oscillator
  • DVA 44.11
  • WLK 76.23

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About WLK Westlake Corporation

Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.

Share on Social Networks: